Active, Not Recruiting
Continuous Glucose Monitoring in Intensive Care Unit
Led by Institute for Clinical and Experimental Medicine · Updated on 2026-06-23
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.
CONDITIONS
Brief Title
Continuous Glucose Monitoring in Intensive Care Unit
Who Can Participate
Eligibility Criteria
Inclusion Criteria:
-
Male or female patients, of 18 to 80 years of age, undergoing one of the following surgical procedures and post-operative care at ICU:
- pancreas surgery - total or partial pancreas resection
- orthotopic liver transplantation
- simultaneous pancreas and kidney transplantation
- patients with diabetes mellitus undergoing major surgery
-
Patient must have signed the Patient Informed Consent Form.
Exclusion Criteria:
Any criteria that would disable surgical procedures involved
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here